Yoshiyuki Inada
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology 7
-
- Renin-Angiotensin System Studies 7
-
- Hormonal Regulation and Hypertension 7
- Organic Chemistry top 5%
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects 7
-
- Receptor Mechanisms and Signaling 8
- Protein Hydrolysis and Bioactive Peptides 6
- Enzyme function and inhibition 5
-
- Nitric Oxide and Endothelin Effects 5
- Co-authors
- Kohei NishikawaKeiji KuboZen‐ichi TerashitaTakeo WadaTakehiko NakaYasuhisa KoharaYumiko ShiboutaEiko Imamiya
- Journals
- Biochemical and Biophysical Research Communications (1 paper)Journal of Medicinal Chemistry (4 papers)International Journal of Pharmaceutics (1 paper)
- Partner nations
- Japan
In The Last Decade
Yoshiyuki Inada
34 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 100
- Biochemistry 152
- Cardiology and Cardiovascular Medicine 412
- Endocrinology, Diabetes and Metabolism 242
- Organic Chemistry 413
- Pharmacology 192
Countries citing papers authored by Yoshiyuki Inada
This map shows the geographic impact of Yoshiyuki Inada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiyuki Inada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiyuki Inada more than expected).
Fields of papers citing papers by Yoshiyuki Inada
This network shows the impact of papers produced by Yoshiyuki Inada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiyuki Inada. The network helps show where Yoshiyuki Inada may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yoshiyuki Inada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 17 | |
| 2 | 1997 | 12 | |
| 3 | 1997 | 122 | |
| 4 | 1997 | 2 | |
| 5 | Angiotensin II receptor antagonistic action of candesartan (CV-11974) in the rabbit aorta | 1996 | 2 |
| 6 | 1996 | 14 | |
| 7 | 1996 | 15 | |
| 8 | 1995 | 15 | |
| 9 | 1994 | 2 | |
| 10 | 1994 | 2 | |
| 11 | 1993 | 111 | |
| 12 | 1993 | 117 | |
| 13 | 1993 | 126 | |
| 14 | 1992 | 12 | |
| 15 | 1990 | 14 | |
| 16 | 1988 | 21 | |
| 17 | 1988 | 12 | |
| 18 | 1988 | 5 | |
| 19 | 1982 | 7 | |
| 20 | 1979 | 39 |
About Yoshiyuki Inada
Yoshiyuki Inada is a scholar working on Biochemistry, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 35 papers that have together received 1.4k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (8 papers), Eicosanoids and Hypertension Pharmacology (7 papers), Inflammatory mediators and NSAID effects (7 papers), Renin-Angiotensin System Studies (7 papers), Hormonal Regulation and Hypertension (7 papers), Protein Hydrolysis and Bioactive Peptides (6 papers), Nitric Oxide and Endothelin Effects (5 papers) and Enzyme function and inhibition (5 papers). The work is most often cited by research in Biochemistry (152 citations), Cardiology and Cardiovascular Medicine (412 citations) and Endocrinology, Diabetes and Metabolism (242 citations). Yoshiyuki Inada has collaborated with scholars based in Japan. Frequent co-authors include Kohei Nishikawa, Keiji Kubo, Zen‐ichi Terashita, Takeo Wada, Takehiko Naka, Yasuhisa Kohara, Yumiko Shibouta, Eiko Imamiya, Susumu Tsushima and Hiroaki Nomura. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.